Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research (Q34581504)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research |
scientific article |
Statements
1 reference
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research (English)
1 reference
Arnaud D Roth
1 reference
Nicola Fazio
1 reference
Roger Stupp
1 reference
Stephen Falk
1 reference
Jürg Bernhard
1 reference
Piercarlo Saletti
1 reference
Dieter Köberle
1 reference
Markus M Borner
1 reference
Kaspar Rufibach
1 reference
Rudolf Maibach
1 reference
Martin Wernli
1 reference
Martin Leslie
1 reference
Robert Glynne-Jones
1 reference
Lukas Widmer
1 reference
Matthew Seymour
1 reference
Filippo de Braud
1 reference
Swiss Group for Clinical Cancer Research
1 reference
1 August 2007
1 reference
1 reference
25
1 reference
22
1 reference
3217-3223
1 reference
Identifiers
1 reference
1 reference